These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 19018741
1. [Management of anemia in chronic kidney disease]. López Gómez JM. Nefrologia; 2008; 28 Suppl 3():63-6. PubMed ID: 19018741 [Abstract] [Full Text] [Related]
2. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F. Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [Abstract] [Full Text] [Related]
3. [Guidelines for the treatment of anemia in chronic renal failure]. Triolo G, Italian Society of Nephrology. G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504 [Abstract] [Full Text] [Related]
4. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease]. Alcázar Arroyo R. Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744 [Abstract] [Full Text] [Related]
5. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration. Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD. Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469 [Abstract] [Full Text] [Related]
10. [Incidence and management of anemia in renal transplantation: an observational-French study]. Choukroun G, Deray G, Glotz D, Lebranchu Y, Dussol B, Bourbigot B, Lefrançois N, Cassuto-Viguier E, Toupance O, Hacen C, Lang P, Mazouz H, Martinez F. Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417 [Abstract] [Full Text] [Related]
14. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data. Locatelli F, Covic A, Macdougall IC, Wiecek A, ORAMA Study Group. J Nephrol; 2008 Jan; 21(4):592-603. PubMed ID: 18651551 [Abstract] [Full Text] [Related]
15. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now? Singh AK. Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260 [Abstract] [Full Text] [Related]
16. [Erythropoiesis-stimulating agents in chronic kidney disease: which route of administration?]. Borrelli S, Baldanza D, Scigliano R, Catapano F, Grimaldi M, Calabria M, Zamboli P, Minutolo R, De Nicola L, Conte G. G Ital Nefrol; 2009 Dec; 26(1):31-7. PubMed ID: 19255962 [Abstract] [Full Text] [Related]